Nureca Ltd
NURECANureca Ltd
NURECA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 374.07 | 1.84 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.58 | 5.12 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Nureca Ltd is engaged in the marketing of home healthcare & wellness products
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.02 | 20.07 | 61.99 | 99.49 | 216.27 | 263.25 | 118.43 | 111.50 | ||||||||
Raw Materials | 0.02 | 15.68 | 50.16 | 67.49 | 120.01 | 159.55 | 44.76 | 107.48 | ||||||||
| Power & Fuel Cost | 0.00 | 0.02 | 0.04 | 0.01 | 0.16 | 0.20 | ||||||||||
| Employee Cost | 0.00 | 0.89 | 3.16 | 4.58 | 9.91 | 16.06 | ||||||||||
| Selling & Administrative Expenses | 0.00 | 11.12 | 19.66 | 44.81 | 51.41 | 29.99 | ||||||||||
| Operating & Other expenses | 0.00 | -9.35 | -0.61 | -17.50 | -20.99 | 35.32 | ||||||||||
EBITDA | 0.00 | 4.39 | 9.15 | 9.75 | 64.36 | 63.21 | -7.90 | 4.02 | ||||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.06 | 0.37 | 0.42 | 1.48 | 2.39 | 2.33 | ||||||||
| PBIT | 0.00 | 4.38 | 9.09 | 9.38 | 63.94 | 61.73 | -10.29 | 1.69 | ||||||||
| Interest & Other Items | 0.00 | 0.06 | 0.24 | 0.77 | 1.60 | 0.74 | 0.45 | 0.41 | ||||||||
| PBT | 0.00 | 4.32 | 8.85 | 8.61 | 62.34 | 60.99 | -10.74 | 1.28 | ||||||||
| Taxes & Other Items | 0.00 | 1.21 | 2.61 | 2.22 | 15.96 | 16.02 | -2.49 | 0.32 | ||||||||
| Net Income | 0.00 | 3.11 | 6.24 | 6.39 | 46.38 | 44.97 | -8.25 | 0.96 | ||||||||
| EPS | 0.00 | 4.45 | 891.43 | 912.86 | 92.11 | 44.97 | -8.25 | 0.96 | ||||||||
| DPS | 0.00 | — | 0.00 | 0.00 | 2.00 | 3.00 | 0.00 | 0.00 | ||||||||
| Payout ratio | — | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nureca Ltd | -43.53 | 1.84 | — |
| Sun Pharmaceutical Industries Ltd | 34.86 | 4.98 | 0.93% |
| Cipla Ltd | 35.05 | 4.14 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.26 | 4.12 | 0.70% |
Price Comparison
Compare NURECA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 24, 2022
Dividend/Share
₹3.00
Ex DateEx Date
Feb 24, 2022
Cash Dividend
Ex DateEx DateSep 21, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Sep 21, 2021
News & Opinions
Nureca Standalone December 2022 Net Sales at Rs 27.84 crore, down 42.1% Y-o-Y
10 months ago•Moneycontrol
Nureca Consolidated December 2022 Net Sales at Rs 27.79 crore, down 42.2% Y-o-Y
10 months ago•Moneycontrol
Nureca consolidated net profit declines 93.66% in the December 2022 quarter
10 months ago•Business Standard
Sensex shed 236 pts, Nifty at 18,028; Nureca zooms 20%, Coforge and Paytm rise 4% each
10 months ago•Business Today
Nureca shares rebound 25% from day’s low amid heavy volumes, up 17%
10 months ago•Business Today
Agri-Tech (India) Ltd leads gainers in ‘B’ group
10 months ago•Business Standard
Bharat Immunological & Biological Corporation Ltd leads gainers in ‘B’ group
11 months ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 42.62%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.01% to 0.04%